These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36780588)
1. Design and Development of a Web-Based Prospective Nationwide Registry for Ocular Inflammatory Diseases: UVEITE.PT - The Portuguese Ocular Inflammation Registry. Leal I; Nogueira V; Matos DB; Araújo J; Berens O; Ribeiro M; Furtado MJ; Liverani M; Silva MI; Guedes M; Cordeiro M; Ribeiro M; José P; Barão R; Nunes Ferreira R; Fonseca S; Mano S; Pina S; Santos MJ; Fonseca JE; Fonseca C; Figueira L Ocul Immunol Inflamm; 2024 Apr; 32(3):342-350. PubMed ID: 36780588 [TBL] [Abstract][Full Text] [Related]
2. Design, development and deployment of a web-based interoperable registry for inherited retinal dystrophies in Portugal: the IRD-PT. Marques JP; Carvalho AL; Henriques J; Murta JN; Saraiva J; Silva R Orphanet J Rare Dis; 2020 Oct; 15(1):304. PubMed ID: 33109251 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. Pimentel MA; Browne EN; Janardhana PM; Borkar DS; Tham VM; Uchida A; Vinoya AC; Acharya NR JAMA Ophthalmol; 2016 Sep; 134(9):1001-6. PubMed ID: 27387135 [TBL] [Abstract][Full Text] [Related]
4. The role of a multicentre data repository in ocular inflammation: The Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS). Ng SMS; Low R; Pak C; Lai S; Lee B; McCluskey P; Symes R; Invernizzi A; Tsui E; Sitaula RK; Kharel M; Khatri A; Utami AN; La Distia Nora R; Putera I; Sen A; Agarwal M; Mahendradas P; Biswas J; Pavesio C; Cimino L; Sobrin L; Kempen JH; Gupta V; Agrawal R; Eye (Lond); 2023 Oct; 37(15):3084-3096. PubMed ID: 36918629 [TBL] [Abstract][Full Text] [Related]
5. Big Data-Based Epidemiology of Uveitis and Related Intraocular Inflammation. Akhter M; Toy B Asia Pac J Ophthalmol (Phila); 2021 Jan-Feb 01; 10(1):60-62. PubMed ID: 33512828 [TBL] [Abstract][Full Text] [Related]
7. Challenges, facilitators and barriers to the adoption and use of a web-based national IRD registry: lessons learned from the IRD-PT registry. Marques JP; Vaz-Pereira S; Costa J; Marta A; Henriques J; Silva R Orphanet J Rare Dis; 2022 Aug; 17(1):323. PubMed ID: 36028864 [TBL] [Abstract][Full Text] [Related]
8. [Observational study of QuantiFERON® management for ocular tuberculosis diagnosis: Analysis of 244 consecutive tests]. Amara A; Ben Salah E; Guihot A; Fardeau C; Touitoue V; Saadoun D; Bodaghi B; Sève P; Trad S Rev Med Interne; 2021 Mar; 42(3):162-169. PubMed ID: 33143863 [TBL] [Abstract][Full Text] [Related]
9. Demographic and Clinical Characteristics of Uveitis in Turkey: The First National Registry Report. Yalçındağ FN; Özdal PC; Özyazgan Y; Batıoğlu F; Tugal-Tutkun I; Ocul Immunol Inflamm; 2018; 26(1):17-26. PubMed ID: 27467500 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as a research tool for identification of patients with uveitis and scleritis. Uchiyama E; Faez S; Nasir H; Unizony SH; Plenge R; Papaliodis GN; Sobrin L Ophthalmic Epidemiol; 2015 Apr; 22(2):139-41. PubMed ID: 25777314 [TBL] [Abstract][Full Text] [Related]
13. Treatment Exit Options for Non-infectious Uveitis (TOFU): Study Protocol for a Prospective Clinical Registry. Li JQ; Heinz C; Dell J; Schmid M; Finger RP Ophthalmic Epidemiol; 2022 Feb; 29(1):31-38. PubMed ID: 33615986 [TBL] [Abstract][Full Text] [Related]
14. Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Sun MM; Kelly SP; Mylavarapu Bs AL; Holland GN; Coleman AL; Yu F; Hsu Ms S; Lum F; Gordon LK Ophthalmology; 2021 Jun; 128(6):910-919. PubMed ID: 33166553 [TBL] [Abstract][Full Text] [Related]
15. [Registry-based research in ophthalmology]. Li J; Heinz C; Finger RP Ophthalmologe; 2018 Oct; 115(10):826-831. PubMed ID: 29766264 [TBL] [Abstract][Full Text] [Related]
16. [New possibilities in therapy of ocular inflammation in rheumatic diseases]. Razumova IY; Godzenko AA Vestn Oftalmol; 2022; 138(6):108-114. PubMed ID: 36573954 [TBL] [Abstract][Full Text] [Related]
17. Web-enabled registry of inherited bleeding disorders in Portugal: conditions and perception of the patients. Teixeira L; Ferreira C; Santos BS; Saavedra V Haemophilia; 2012 Jan; 18(1):56-62. PubMed ID: 21651675 [TBL] [Abstract][Full Text] [Related]
18. [Colchicine and non-severe ocular inflammation excluding Behcet's disease: 16 cases and literature review]. Rogier T; Auvens C; Thibault T; Mouries-Martin S; Muller G; El Hssaini N; Turcu A; Besancenot JF; Bielefeld P; Devilliers H Rev Med Interne; 2022 Nov; 43(11):640-644. PubMed ID: 36068122 [TBL] [Abstract][Full Text] [Related]
19. Association between advanced glycation end products and uveitis/scleritis activity in patients with active immune-mediated ocular inflammatory diseases. Sukon N; Choopong P; Tungsattayathitthan U; Tesavibul N; Sanpan W; Boonsopon S Int Ophthalmol; 2024 Feb; 44(1):33. PubMed ID: 38329659 [TBL] [Abstract][Full Text] [Related]
20. A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. Squires H; Poku E; Bermejo I; Cooper K; Stevens J; Hamilton J; Wong R; Denniston A; Pearce I; Quhill F Health Technol Assess; 2017 Nov; 21(68):1-170. PubMed ID: 29183563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]